Biotechnology in United Kingdom

June 2020 | 46 pages | ID: BACB3F1D49BEN
MarketLine

Abstracts

Biotechnology in United Kingdom

SUMMARY

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
• The UK biotechnology market had total revenues of $11.4bn in 2019, representing a compound annual growth rate (CAGR) of 8.2% between 2015 and 2019.
• The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $7.5bn, equivalent to 66% of the market's overall value.
• Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

REASONS TO BUY

• What was the size of the United Kingdom biotechnology market by value in 2019?
• What will be the size of the United Kingdom biotechnology market in 2024?
• What factors are affecting the strength of competition in the United Kingdom biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up the United Kingdom's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. Were there any notable product approvals in 2019?
7.5. What has been the rationale behind recent M&A activity?
7.6. How might COVID-19 affect the competitive landscape?

8 COMPANY PROFILES

8.1. AstraZeneca PLC
8.2. Novartis AG
8.3. GE Healthcare
8.4. Sanofi SA

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Kingdom biotechnology industry value: $ billion, 2015-19
Table 2: United Kingdom biotechnology industry category segmentation: $ billion, 2019
Table 3: United Kingdom biotechnology industry geography segmentation: $ billion, 2019
Table 4: United Kingdom biotechnology industry value forecast: $ billion, 2019-24
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: Annual Financial Ratios
Table 7: AstraZeneca PLC: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Annual Financial Ratios (Continued)
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: GE Healthcare: key facts
Table 14: GE Healthcare: Key Employees
Table 15: GE Healthcare: Key Employees Continued
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: Annual Financial Ratios
Table 18: Sanofi SA: Key Employees
Table 19: Sanofi SA: Key Employees Continued
Table 20: United Kingdom size of population (million), 2015-19
Table 21: United Kingdom gdp (constant 2005 prices, $ billion), 2015-19
Table 22: United Kingdom gdp (current prices, $ billion), 2015-19
Table 23: United Kingdom inflation, 2015-19
Table 24: United Kingdom consumer price index (absolute), 2015-19
Table 25: United Kingdom exchange rate, 2015-19

List Of Figures

LIST OF FIGURES

Figure 1: United Kingdom biotechnology industry value: $ billion, 2015-19
Figure 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2019
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: United Kingdom biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2019